Botanical Elastase-Inhibiting Composition for Wrinkle Prevention
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing anti-aging skin care products are inadequate in inhibiting elastase activity, which leads to elastin degradation and wrinkle formation, necessitating the development of new and effective elastase inhibitors.
Innovation Solution
A botanical extract-containing composition comprising Potentilla glabra leaf, Bombax malabaricum flower, Amomum villosum seed, Amomum kravanh seed, or Cornus officinalis fruit extracts, or combinations thereof, formulated as topical or oral compositions to inhibit elastase activity in the skin.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing anti-aging skin care products are used, then skin aging is addressed to some extent, but elastase activity is not effectively inhibited, leading to continued elastin degradation and wrinkle formation
Solution Approach 1:
The patent changes the chemical parameters of elastase inhibitors by using specific botanical extracts (Potentilla glabra leaf, Bombax malabaricum flower, Amomum villosum seed, Amomum kravanh seed, Cornus officinalis fruit) that contain unique active compounds. These botanical sources provide different chemical profiles compared to conventional inhibitors, achieving enhanced elastase activity inhibition while maintaining safety.
Solution Approach 2:
The patent employs composite botanical extracts containing multiple active components working synergistically. Each botanical source contributes different bioactive molecules that collectively provide superior elastase inhibition compared to single-compound inhibitors. The composite nature of these extracts enhances both effectiveness and safety profiles.
2Reliability
If stronger elastase inhibitors are developed to prevent elastin degradation, then wrinkle formation is reduced, but safety and tolerability must be maintained
Solution Approach 1:
The patent utilizes natural botanical extracts that are biodegradable and easily metabolized by the body. These natural sources provide temporary but effective inhibition, avoiding the accumulation of harmful substances. The extracts are derived from plants that have been used traditionally in cosmetics, ensuring safety through established safety profiles.
Solution Approach 2:
The botanical extracts act as intermediary substances that modulate elastase activity through multiple mechanisms. They provide gentle, progressive inhibition rather than abrupt strong blocking, allowing the skin to adapt while maintaining safety. The extracts serve as natural mediators between the harmful elastase enzyme and the elastin substrate.
Data Source
AI summary
A composition for administration to a subject is disclosed. The composition comprises at least one botanical active component. The botanical active component is present in the composition in an amount effective to inhibit elastase activity in the skin of the subject. The botanical active component comprises at least one extract selected from the group consisting of: i) an extract of Potentilla glabra leaf; ii) an extract of Bombax malabaricum flower; iii) an extract of Amomum villosum seed; iv) an extract of Amomum kravanh fruit; v) an extract of Cornus officinalis fruit; and vi) combinations of i) to v). The composition may be in the form of a topical composition, e.g., for topical application. The composition may also be in the form of an oral composition, e.g., for ingestion. A method of inhibiting elastase activity in the skin of a subject is also provided. The method comprises administering an effective amount of the composition to the subject.